EXPLORATION OF HYDROXYL SUBSTITUTED REGORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA THROUGH MOLECULAR DOCKING. FMHR. 2026;4(3):3863-3874. Accessed November 9, 2026. https://fmhr.net/index.php/fmhr/article/view/3740